SCHEMBL7303330

SCHEMBL7303330

CCCC(=O)c1nc(CCC)n(Cc2ccc(-c3ccccc3C(=O)OC(C)(C)C)cc2)c1C#N

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.47
AGTR1 P30556 1/20 0.46
AGTR2 P50052 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7311672 0.95 ACHE (0.49) AGTR1AGTR2
SCHEMBL7302766 0.89 ACHE (0.50) AGTR1AGTR2
SCHEMBL7300220 0.87 ACHE (0.51) AGTR1AGTR2
SCHEMBL7302941 0.85 ACHE (0.49) AGTR1AGTR2
SCHEMBL7301206 0.85 AGTR1 (0.50) AGTR1AGTR2
SCHEMBL7305319 0.84 PPARG (0.46) PPARGAGTR1AGTR2
SCHEMBL7307378 0.82 ACHE (0.51) AGTR1AGTR2
SCHEMBL7310213 0.81 PPARG (0.56) PPARG
SCHEMBL7310122 0.81 ACHE (0.48) AGTR1AGTR2
SCHEMBL7301575 0.80 ACHE (0.51) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0545912-B1 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-04-25 EP disclosed
US-5646171-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1997-07-08 US disclosed
US-5616599-A HYPOTENSIVE AGENTS FOR CARDIOVASCULAR DISORDER SANKYO COMPANY, LIMITED (JP) 1997-04-01 US disclosed
EP-0545912-A2 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1993-06-09 EP disclosed
EP-0503785-A1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1992-09-16 EP disclosed